Rationing antiretroviral therapy for HIV/AIDS in Africa: Choices and consequences

PLoS Medicine

Volumn 2, Issue 11, 2005, Pages 1098-1104

  Rosen, Sydney ^a   Sanne, Ian ^b,c   Collier, Alizanne ^a   Simon, Jonathon L ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c RIGHT TO CARE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DIRECTIVE COUNSELING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LEUKOCYTE COUNT; MEDICAL SERVICE; PATIENT COMPLIANCE; REVIEW; SUSTAINABLE DEVELOPMENT; UNEMPLOYMENT; AFRICA; ARTICLE; CULTURAL FACTOR; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; LEGAL ASPECT; MANAGEMENT; SOCIAL STATUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; ANTI-RETROVIRAL AGENTS; CULTURAL CHARACTERISTICS; HEALTH CARE RATIONING; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; POLICY MAKING; SOCIAL CONDITIONS;

EID: 28444458175     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020303     Document Type: Review

References (49)

1. Rosen S, Sanne I, Collier A, Simon JL (2005) Hard choices: Rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet 365: 354-356.
2. Stiglitz JE (2004) Economics of the public sector. Second Edition. New York: Norton. 754 p.
3. European Observatory on Health Systems and Policies (2005) Glossary. Available: http://www.euro.who.int/observatory/glossary/toppage. Accessed 22 February 2005.
4. Maynard A (1999) Rationing health care: An exploration. Health Policy 49: 5-11.
5. Auvert B, Males S, Puren A, Taljaard D, Carael M, et al. (2004) Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr 36: 613-621.
6. Mitka M (2002) MTCT-Plus program has two goals: End maternal HIV transmission + treat mothers. JAMA 288: 153-154.
7. [Anonymous] (2005) Botswana: Anti-AIDS drugs for armed forces. Available: http://www.plusnews.org/AIDSReport.ASP?ReportID=4575. Accessed 15 March 2005.
8. [Anonymous] (2005) Zambia: University launches free ARV treatment on campus. Available: http://www.plusnews.org/AIDSreport.asp?ReportID=4446. Accessed 4 February 2005.
9. [Anonymous] (2005) Uganda: Free ARVs for HIV-positive civil servants. Available: http://www.plusnews.org/AIDSreport.asp?ReportID=4680. Accessed 8 April 2005.
10. [Anonymous] (2004) Zambia: MSF says rural poor lack access to AIDS drugs. Available: http://www.plusnews.org/AIDSReport.ASP?ReportID=2971. Accessed 28 January 2004.
11. Macklin R (2004) Ethics and equity in access to HIV treatment: 3 by 5 initiative. Available: http://www.who.int/ethics/en/backgroundmacklin.pdf. Accessed 22 February 2005.
12. Blower SM, Bodine E, Kahn J, McFarland W (2005) The antiretroviral rollout and drug-resistant HIV in Africa: Insights from empirical data and theoretical models. AIDS 19: 1-14.
13. Salomon JA, Hogan DR, Stover J, Stanecki KA, Walker N, et al. (2005) Integrating HIV prevention and treatment: From slogans to impact. PLoS Med 2: e16. DOI: 10.1371/journal.pmed.0020016
14. [Anonymous] (2004) Africa: Treatment criteria - Deciding who gets to live. Available: http://www.plusnews.org/webspecials/ARV/afrdec.asp. Accessed 17 December 2004.
15. [Anonymous] (2004) Zambia: Second-class women left behind in access queue. Available: http://www.plusnews.org/AIDSreport.asp?ReportID=4295. Accessed 18 December 2004.
16. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, et al. (2003) Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 34: 281-288.
17. Garcia DO, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, et al. (2002) Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr 30: 105-110.
18. Hosseinipour MC, Kazembe PN, Sanne IM, van der Horst CM (2002) Challenges in delivering antiretroviral treatment in resource poor countries. AIDS 16(Suppl 4): S177-S187.
19. Khumalo-Sakutukwa G, Routh J, Fiamma A, Lane T, Fritz K, et al. (2004) Facilitating acceptance of HIV testing: Mobile HIV voluntary counseling and testing in Sub-Saharan Africa [abstract]. In: XVth International AIDS Conference; Bangkok, Thailand, July 11-16. Abstract nr WeOrE1268.
20. [Anonymous] (2005) Ghana: Government makes ARV drugs more widely available. Available: http://www.plusnews.org/AIDSreport.asp?ReportID=4356. Accessed 13 January 2005.
21. Dor A, Gertler P, Van Der GJ (1987) Non-price rationing and the choice of medical care providers in rural Cote d'Ivoire. J Health Econ 6: 291-304.
22. Melese M, Alemayehu W, Friedlander E, Courtright P (2004) Indirect costs associated with accessing eye care services as a barrier to service use in Ethiopia. Trop Med Int Health 9: 426-431.
23. Ensor T, Cooper S (2004) Overcoming barriers to health service access: Influencing the demand side. Health Policy Plan 19: 69-79.
24. Scott VE, Chopra M, Conrad L, Ntuli A (2005) How equitable is the scaling up of HIV service provision in South Africa? S Afr Med J 95: 109-113.
25. Wilson DP, Blower SM (2005) Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med 2: e50. DOI: 10.1371/journal.pmed.0020050
26. Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings (2004) Scaling up treatment for the global AIDS pandemic: Challenges and opportunities. Washington (District of Columbia): National Academies Press. 325 p.
27. Orrell C, Bangsberg DR, Badri M, Wood R (2003) Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17: 1369-1375.
28. Haacker M, editor (2004) The macroeconomics of HIV/AIDS. Available: http://www.imf.org/external/pubs/ft/AIDS/eng/. Accessed 7 August 2005.
29. [Anonymous] (2004) Biz/ed economics glossary. Available: http://bized.ac.uk/glossary/econglos.htm. Accessed 9 February 2004.
30. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, et al. (2004) Decline in HIV infectivity following the introduction of highly active ART. AIDS 18: 81-88.
31. Attawell K, Mundy J (2003) Provision of ART in resource-limited settings: A review of experience up to August 2003. Available: http://www.who.int/3by5/ publications/documents/en/ARTpaper_DFID_WHO.pdf. Accessed 11 August 2005.
32. Kilewo C, Massawe A, Lyamuya E, Semali I, Kalokola F, et al. (2001) HIV counseling and testing of pregnant women in sub-Saharan Africa: Experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 28: 458-462.
33. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M (2001) Women's barriers to HIV-1 testing and disclosure: Challenges for HIV-1 voluntary counselling and testing. AIDS Care 13: 595-603.
34. [Anonymous] (2004) Africa: Focus on Mozambique - ART in Africa. Available: http://www.plusnews.org/webspecials/ARV/ovrmoz.asp. Accessed 16 December 2004.
35. [Anonymous] (2004) Increased number of low-income HIV-positive people, high price of Fuzeon creating care 'rationing.' Available: http://www. kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=21639. Accessed 13 January 2004.
36. Loewenson R, McCoy D (2004) Access to antiretroviral treatment in Africa. BMJ 328: 241-242.
37. Cheek R (2001) Playing God with HIV: Rationing HIV treatment in southern Africa. Available: http://www.iss.org.za/PUBS/ASR/10No4/Cheek.html. Accessed 22 February 2005.
38. Daniels N (2005) Fair process in patient selection for antiretroviral treatment in WHO's goal of 3 by 5. Lancet 366: 169-171.
39. McGough LJ, Reynolds SJ, Quinn TC, Zenilman JM. Which patients first? Setting priorities for antiretroviral therapy where resources are limited. Am J Public Health 95: 1173-1180.
40. World Health Organization (2004) "3 x 5" progress report. Geneva: World Health Organization. Available: http://www.who.int/3by5/ progressreport05/en/. Accessed 8 August 2005.
41. [Anonymous] (2004) The treatment era: ART in Africa: Treatment map. Available: http://www.plusnews.org/aids/treatment.asp. Accessed 12 January 2004.
42. [Anonymous] (2005) Malawi hopes to treble AIDS drug rollout. Available: http://www.iol.co.za/index.php?set_id=1&click_id=68&art_id= qw110535084416M443. Accessed 15 January 2005.
43. [Anonymous] (2005) Nigeria: Authorities predict 250,000 people on ARVs by mid-2006. Available: http://www.plusnews.org/AIDSreport.asp?ReportID=4537. Accessed 1 March 2005.
44. South Africa Department of Health (2003) Operational plan for comprehensive HIV and AIDS care, management, and treatment for South Africa. Available: http://www.info.gov.za/otherdocs/2003/aidsplan.pdf. Accessed 22 February 2005.
45. Wines M (2004) Zambia's president vows to extend AIDS treatment by 2005. Available: http://query.nytimes.com/gst/health/article-page.html?res= 9504E6D8163DF936A15753C1A9629C8B63. Accessed 7 August 2005.
46. Joint United Nations Programme on HIV/AIDS (2004) 2004 Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS. 231 p.
47. Desvarieux M, Landman R, Liautaud B, Girard PM (2005) Antiretroviral therapy in resource-poor countries: Illusions and realities. Am J Public Health 95: 1117-1122.
48. Ekouevi DK, Rouet F, Becquet R, Inwoley A, Viho I, et al. (2004) Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa. J Acquir Immune Defic Syndr 36: 755-757.
49. Gill CJ, Hamer D, Simon JL, Thea DM, Sabin L (2005) No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 19: 1243-1249.